Jonathan Zalevsky
2019
In 2019, Jonathan Zalevsky earned a total compensation of $7.3M as Chief Research and Development Officer at Nektar Therapeutics.
Compensation breakdown
| Option Awards | $3,552,006 |
|---|---|
| Salary | $582,000 |
| Stock Awards | $3,131,971 |
| Other | $8,120 |
| Total | $7,274,153 |
Zalevsky received $3.6M in option awards, accounting for 49% of the total pay in 2019.
Zalevsky also received $582K in salary, $3.1M in stock awards and $8.1K in other compensation.
Rankings
In 2019, Jonathan Zalevsky's compensation ranked 1,295th out of 13,971 executives tracked by ExecPay. In other words, Zalevsky earned more than 90.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,295 out of 13,971 | 91st |
Division Manufacturing | 455 out of 5,701 | 92nd |
Major group Chemicals And Allied Products | 139 out of 2,200 | 94th |
Industry group Drugs | 111 out of 1,886 | 94th |
Industry Pharmaceutical Preparations | 82 out of 1,398 | 94th |
Source: SEC filing on April 30, 2021.
Zalevsky's colleagues
We found three more compensation records of executives who worked with Jonathan Zalevsky at Nektar Therapeutics in 2019.